The safety and efficacy of topiramate in male patients with abdominal obesity: a 6-month double-blind, randomized, placebo-controlled study with a 6-month open-label extension.
Latest Information Update: 07 Jul 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2007 Status change
- 19 Nov 2005 New trial record.